Dr. Michael Joel Consolo, DO

Dr. Consolo practices at Inland Urology Medical Group Inc in Pomona, California.

Dr. Consolo's NPI, 1699038034, was assigned on June 20, 2012. Dr. Consolo graduated from WesternU College of Osteopathic Medicine of the Pacific in 2012. Dr. Consolo holds California license 20A15277.

Dr. Consolo's primary practice is Inland Urology Medical Group Inc, at 210 W Bonita Ave, Pomona, CA 91767 in Los Angeles County. The practice phone is (909) 623-3428.

Dr. Consolo's primary practice is Inland Urology Medical Group Inc in Pomona, California. Dr. Consolo is also affiliated with Pomona Valley Hospital Medical Center. The medical group on file is Inland Urology Medical Group. Dmand AI also links Dr. Consolo to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Consolo practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Consolo's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Consolo is board certified in urological surgery by the AOA Board of Surgery. Dr. Consolo is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate inflammation or infection among the conditions Dr. Consolo treats.

CMS data shows 811 Medicare services from Dr. Consolo across 16 procedure codes in 2024, for 312 Medicare patients. Medicare paid $62,628 for them.

CMS counts 312 Medicare patients who saw Dr. Consolo in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Consolo's median patient age at 67, with 30% women.

In 2024, Dr. Consolo wrote 2,907 Medicare Part D claims for 729 patients. 87% of them were for generic drugs. CMS names the drug for 2,806 of them, across 25 drugs with 11 or more claims each, at $254,672 in total drug cost. In 2023, CMS named 2,819 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Consolo for performance year 2024, reported as part of a group. Dr. Consolo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Consolo as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Consolo, published from 2020 to 2021. Dr. Consolo's most frequent co-authors are Kirin K. Syed, DO, Gordon A. Brown, DO and Bradley David Figler, MD.

CMS Open Payments shows 477 general payments to Dr. Consolo from 58 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Abbvie Inc. paid the most, $1,581.

Dr. Consolo graduated from WesternU College of Osteopathic Medicine of the Pacific in 2012. Dr. Consolo is a member of AOA.

Dr. Consolo is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.